Metronidazole Dosing Guidelines for Pediatric Patients

Dosing Recommendations

For a 5-year-old child weighing 20kg with Clostridium difficile infection, the recommended dose of metronidazole is 7.5 mg/kg/dose three or four times daily for 10 days, with a maximum dose of 500mg per dose, as recommended by the Infectious Diseases Society of America 1, 2
The standard pediatric dosing for other anaerobic infections remains 7.5 mg/kg/dose three or four times daily, with a duration of 7-10 days depending on clinical response and indication 1

Current guidelines prefer vancomycin or fidaxomicin over metronidazole for C. difficile infections when available, due to concerns about neurotoxicity and treatment failure 3, 4
Avoid prolonged or repeated courses of metronidazole due to the risk of cumulative and potentially irreversible neurotoxicity 3, 4

Ensure completion of the full course of therapy even if symptoms improve before completion, and monitor for common side effects including nausea, metallic taste, and gastrointestinal discomfort 1
For C. difficile infection, if the patient doesn't respond to metronidazole within 5-7 days, consider switching to oral vancomycin, as recommended by the Infectious Diseases Society of America 1, 2

The Infectious Diseases Society of America recommends that metronidazole is no longer first-line therapy for Clostridium difficile Infection (CDI), and instead suggests vancomycin (125 mg orally 4 times daily) or fidaxomicin (200 mg twice daily) as preferred agents 5, 6
For CDI treatment, if metronidazole must be used due to limited access to preferred agents, the adult equivalent dosing is 500 mg orally 3 times daily for 10 days, which can be adjusted for pediatric patients 5, 6
The Infectious Diseases Society of America advises against repeated or prolonged courses of metronidazole due to the risk of cumulative and potentially irreversible neurotoxicity 5, 6
Metronidazole therapy should not be extended beyond 14 days without compelling justification 5, 6

The Infectious Diseases Society of America notes that no dosage adjustment is needed for renal dysfunction, as metronidazole pharmacokinetics are unaffected by renal failure 7